MREO
Mereo BioPharma
MREO
MREO
72 hedge funds and large institutions have $146M invested in Mereo BioPharma in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $212M → $146M (-$66.5M)
51% less call options, than puts
Call options by funds: $37K | Put options by funds: $75K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
72
Holding in Top 10
–
Calls
$37K
Puts
$75K
Top Buyers
| 1 | +$5.78M | |
| 2 | +$1.2M | |
| 3 | +$1.14M | |
| 4 |
CC
Clearline Capital
New York
|
+$1.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.02M |
Top Sellers
| 1 | -$41.8M | |
| 2 | -$3.02M | |
| 3 | -$1.94M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.81M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.57M |